Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

282.72
+3.121.12%
Post-market: 282.720.00000.00%19:26 EDT
Volume:303.69K
Turnover:85.97M
Market Cap:6.28B
PE:-15.74
High:287.27
Open:281.03
Low:275.00
Close:279.60
Loading ...
Feb 09, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 10, 2023

Major Issues Report

8-K - Current report
Dec 23, 2022

Major Issues Report

8-K - Current report
Dec 19, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Jun 17, 2022

Major Issues Report

8-K - Current report
May 19, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals